The MDS Beacon™

FDA Considers Alternative Dosing Regimen for Dacogen – A supplemental new drug application for an alternative dosing regimen for Dacogen (decitabine) has been accepted by the United States Food and Drug Administration (FDA). The proposed five day regimen consists of a single daily dose of Dacogen with reduced infusion time, and is likely to be more convenient for patients. The current dosing schedule requires three hours of continuous intravenous administration of Dacogen every eight hours for three days. Dacogen has been approved by the FDA as a treatment for myelodysplastic syndromes.  For more information, please see the Eisai press release.

Best of Washington Party – Washingtonian Magazine will hold its annual Best of Washington summer party on Wednesday, July 15 at the National Building Museum in Washington, DC. The event begins at 7 p.m. and ends at 10 p.m. The party features unlimited cocktails and cuisine from over 50 restaurant winners of the magazine’s Best of Washington contests. A portion of the proceeds will be donated to the Leukemia & Lymphoma Society (LLS). Presidential tickets are available at a discount to LLS supporters: use the code LLS1 at the Best of Washington checkout. For more information, please see the Best of Washington 2009 Web site.

Leukemia Cup Regatta – “Sail for the Cures” with the Leukemia & Lymphoma Society (LLS). Upcoming events are scheduled for: July 10 to 12 in Deltaville, VA; July 17 in Beachwood, NJ; and July 16 to 19 in Rocky River, OH. Sailors compete for the Leukemia Cup in honor of a community member with blood cancer with an opportunity to win prizes for raising money to support LLS, including a Fantasy Sail Weekend with world-class sailor and National Regatta Chairman Gary Jobson. For more information, visit the LLS Leukemia Cup Regatta Web site.